Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 3

Conditions studied: Ocular Hypertension

In brief

The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT00332059

Run by

Allergan

People needed

445

Starts

2003-05-01

Expected to finish

2004-09-01

Last updated by the study team

2011-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of glaucoma or ocular hypertension in both eyes
• Patient requires IOP-lowering drug in both eyes

You may not qualify if…

• Uncontrolled medical conditions
• Contraindication to beta-adrenoceptor antagonist therapy

Where it is running

• Study site — Bel Air, Maryland, United States
• Study site — Vienna, Austria
• Study site — Montreal, Quebec, Canada
• Study site — Berlin, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.